Barchart.com
Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Join Barchart Premier to get Screeners that run automatically with the results emailed to you! FREE 30 Day Trial
Menu
Stocks | Futures | Watchlist | News | More
 
or
Watchlist | Portfolio | Dashboard
Site News
Contact
Market:
Menu

Bioxcel Therapeutics Inc (BTAI)

Bioxcel Therapeutics Inc (BTAI)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
News & Headlines for [[ item.sessionDateDisplayLong ]]
Notes
Alerts
Watch
Help
Go To:
BioXcel Therapeutics Announces Proposed Public Offering GlobeNewswire - Thu Nov 21, 3:47PM CST

BTAI : 0.5700 (-3.06%)
BioXcel Therapeutics Reports Third Quarter 2024 Financial Results GlobeNewswire - Thu Nov 14, 6:00AM CST

BTAI : 0.5700 (-3.06%)
BioXcel Therapeutics Advances Pivotal Phase 3 Trials of BXCL501 for Acute Treatment of Agitation Associated with Bipolar Disorders, Schizophrenia, and Alzheimer’s Dementia GlobeNewswire - Tue Nov 12, 6:00AM CST

BTAI : 0.5700 (-3.06%)
BioXcel Therapeutics to Report Third Quarter 2024 Financial Results on November 14, 2024 GlobeNewswire - Fri Nov 8, 6:00AM CST

BTAI : 0.5700 (-3.06%)
BioXcel Therapeutics to Present at ThinkEquity Conference GlobeNewswire - Tue Oct 29, 6:00AM CDT

BTAI : 0.5700 (-3.06%)
BioXcel Therapeutics Announces U.S. Department of Defense Grant to University of North Carolina to Fund Study of BXCL501 (Sublingual Dexmedetomidine) for Treating Acute Stress Disorder GlobeNewswire - Tue Oct 15, 6:00AM CDT

BTAI : 0.5700 (-3.06%)
Anal Cancer Treatment Market Expected to Reach $1.63 Billion by 2030 as Latest Clinical Studies Focus on New Therapies FinancialNewsMedia - Wed Feb 14, 7:31AM CST

EQNX::TICKER_START (NASDAQ:ONCY),(TSX:ONC),(NASDAQ:EXEL),(NYSE:PFE),(NASDAQ:BTAI),(NYSE:BMY) EQNX::TICKER_END

ONCY : 0.9800 (-1.85%)
ONC.TO : 1.37 (-2.14%)
EXEL : 34.83 (+0.52%)
PFE : 25.13 (+0.76%)
BTAI : 0.5700 (-3.06%)
BMY : 58.23 (+0.60%)
Anal Cancer Treatment Market Expected to Reach $1.63 Billion by 2030 as Latest Clinical Studies Focus on New Therapies GlobeNewswire - Wed Feb 14, 7:30AM CST

ONCY : 0.9800 (-1.85%)
ONC.TO : 1.37 (-2.14%)
EXEL : 34.83 (+0.52%)
PFE : 25.13 (+0.76%)
BTAI : 0.5700 (-3.06%)
BMY : 58.23 (+0.60%)
Author
Unlocking AI investment opportunities in healthcare MarketBeat - Thu Nov 16, 2023

AI is revolutionizing healthcare by improving diagnosis and accelerating drug discovery. An often-overlooked sector with a wealth of AI opportunities.

INTC : 24.44 (+1.79%)
NVDA : 146.67 (+0.53%)
RXRX : 5.75 (-4.80%)
RLAY : 4.64 (-0.43%)
EXAI : 4.84 (+3.20%)
RENB : 0.5008 (-0.60%)
BTAI : 0.5700 (-3.06%)
Why Shares of BioXcel Therapeutics Fell This Week Motley Fool - Thu Sep 28, 2023

The company's co-founder is leaving, and layoffs are coming.

BTAI : 0.5700 (-3.06%)

Barchart Exclusives

2 Energy Dividend Stocks Yielding 6% to Pick Now Barchart - 35 minutes ago
These two have been favorites among income-focused investors due to their high and consistent distribution yield. Read more
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.

Free Barchart Webinar

[[ data.userDate ]]
[[ data.eventTime | date: 'EEE, MMM dd, yyyy h:mm a' ]] [[ zone ]]
Reserve Your Spot